Breaking News Instant updates and real-time market news.

AZN

AstraZeneca

$37.39

-0.25 (-0.66%)

10:03
10/12/18
10/12
10:03
10/12/18
10:03

AstraZeneca's olaparib granted orphan status as pancreatic cancer treatment

AstraZeneca's olaparib was granted orphan status as a pancreatic cancer treatment, according to a post to the agency's website. Reference Link

  • 19

    Oct

  • 23

    Oct

  • 07

    Nov

AZN AstraZeneca
$37.39

-0.25 (-0.66%)

09/06/18
HCWC
09/06/18
NO CHANGE
Target $11
HCWC
Buy
H.C. Wainwright impressed by Checkpoint Therapeutics' first clinical data
H.C. Wainwright analyst Joseph Pantginis says Checkpoint Therapeutics' (CKPT) first clinical data in its history "did not disappoint." The data show a "significant clinical benefit" from CK-101 treatment, Pantginis tells investors in a research note. With these safety and efficacy data in hand, Checkpoint's CK-101 may show competitive clinical advantages versus approved EGFR therapies, including AstraZeneca's Tagrisso, at least in the non-small-cell lung carcinoma indication, the analyst contends. He's "impressed" with the data and notes that Checkpoint management has confirmed its intention to move into a pivotal study in 2019 mimicking the Tagrisso Flaura study. Pantginis has a Buy rating on Checkpoint Therapeutics with an $11 price target.
09/14/18
ROTH
09/14/18
NO CHANGE
Target $33
ROTH
Buy
Roth Capital remains bullish on Stemline after AstraZeneca's Lumoxiti approved
Roth Capital analyst Jotin Marango said he had viewed the BLA review for AstraZeneca's (AZN) Lumoxiti for Hairy Cell Leukemia as a relative gauge of what might happen with Stemline's (STML) Elzonris given what he sees as the similarities between the agents. Lumoxiti's approval makes him more bullish on Stemline ahead of the Q1 of 2019 PDUFA date for Elzonris, said Marango, who raised his assumed probability of success for its BLA to 90% from 75%. He raised his price target on Stemline shares to $33 from $30 and keeps a Buy rating on the stock.
09/17/18
PIPR
09/17/18
NO CHANGE
Target $35
PIPR
Neutral
Piper sees Astra's Lynparza as 'much cleaner' than Tesaro's Zejula
Piper Jaffray analyst Christopher Raymond reiterates a Neutral rating and $35 price target on Tesaro (TSRO) after analyzing a year's worth of adverse event reporting as captured by FDA's Adverse Event Reporting System database, which he obtained through a Freedom of Information Act request. The analyst, while cautioning that the database "likely contains inaccuracies and is far from perfect," is "struck by how much cleaner" AstraZeneca's (AZN) Lynparza appears versus Tesaro's Zejula and Clovis Oncology's (CLVS) Rubraca. Further, Raymond is also surprised that Zejula's adverse events rates do not appear to have decreased in any meaningful way year-over-year, despite Tesaro's active down-dosing efforts. Since the analyst thinks PARPi differentiation remains largely around safety, he lowered his Zejula estimates in 2019 and beyond. Lynparza is likely to maintain the upper hand, Raymond tells investors in a research note.
10/08/18
GUGG
10/08/18
INITIATION
GUGG
Buy
AstraZeneca initiated with a Buy at Guggenheim
Guggenheim analyst Seamus Fernandez started AstraZeneca with a Buy rating and 7,018p price target, citing his belief that the company's new product launches in oncology and severe asthma can drive the fastest sales and EPS growth in global pharma.

TODAY'S FREE FLY STORIES

PANW

Palo Alto Networks

$202.61

-3.375 (-1.64%)

07:50
10/19/18
10/19
07:50
10/19/18
07:50
Initiation
Palo Alto Networks initiated  »

Palo Alto Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

CTXS

Citrix

$103.40

-1.73 (-1.65%)

07:48
10/19/18
10/19
07:48
10/19/18
07:48
Initiation
Citrix initiated  »

Citrix initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

HON

Honeywell

$155.22

-2.73 (-1.73%)

07:48
10/19/18
10/19
07:48
10/19/18
07:48
Hot Stocks
Breaking Hot Stocks news story on Honeywell »

Honeywell says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

OZK

Bank OZK

07:47
10/19/18
10/19
07:47
10/19/18
07:47
Recommendations
Bank OZK analyst commentary  »

Stephens says Bank OZK Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 29

    Oct

NUAN

Nuance

$17.27

-0.24 (-1.37%)

07:47
10/19/18
10/19
07:47
10/19/18
07:47
Initiation
Nuance initiated  »

Nuance initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMB

Williams

$26.66

-0.21 (-0.78%)

07:46
10/19/18
10/19
07:46
10/19/18
07:46
Initiation
Williams initiated  »

Williams coverage resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

DLGNF

Dialog Semiconductor

$0.00

(0.00%)

, AAPL

Apple

$215.98

-5.22 (-2.36%)

07:46
10/19/18
10/19
07:46
10/19/18
07:46
Periodicals
Apple chip partner Dialog 'carefully' watching US-China trade, CNBC says »

The CEO of Dialog…

DLGNF

Dialog Semiconductor

$0.00

(0.00%)

AAPL

Apple

$215.98

-5.22 (-2.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NICE

Nice Systems

$105.31

-0.97 (-0.91%)

07:45
10/19/18
10/19
07:45
10/19/18
07:45
Initiation
Nice Systems initiated  »

Nice Systems initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTFC

Wintrust Financial

$79.79

-4.06 (-4.84%)

07:45
10/19/18
10/19
07:45
10/19/18
07:45
Recommendations
Wintrust Financial analyst commentary  »

Wintrust Financial price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TENB

Tenable Holdings

$29.62

-0.65 (-2.15%)

07:44
10/19/18
10/19
07:44
10/19/18
07:44
Initiation
Tenable Holdings initiated  »

Tenable Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

HON

Honeywell

$155.22

-2.73 (-1.73%)

07:44
10/19/18
10/19
07:44
10/19/18
07:44
Hot Stocks
Honeywell expects continued macro strength across major end markets in FY19 »

Says intends to eliminate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

VMW

VMware

$145.51

-2.76 (-1.86%)

, DVMT

Dell Technologies

$94.47

-0.655 (-0.69%)

07:43
10/19/18
10/19
07:43
10/19/18
07:43
Initiation
VMware, Dell Technologies initiated  »

VMware initiated with an…

VMW

VMware

$145.51

-2.76 (-1.86%)

DVMT

Dell Technologies

$94.47

-0.655 (-0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 06

    Dec

OKE

Oneok

$66.94

-0.07 (-0.10%)

07:43
10/19/18
10/19
07:43
10/19/18
07:43
Upgrade
Oneok rating change  »

Oneok upgraded to Buy at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

OZK

Bank OZK

$34.85

-1.57 (-4.31%)

07:42
10/19/18
10/19
07:42
10/19/18
07:42
Hot Stocks
Bank OZK reports combined Q3 charge-offs of $45.5M »

Bank OZK announced last…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 29

    Oct

ZS

Zscaler

$36.75

-1.2 (-3.16%)

07:41
10/19/18
10/19
07:41
10/19/18
07:41
Initiation
Zscaler initiated  »

Zscaler initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

HON

Honeywell

$155.22

-2.73 (-1.73%)

07:40
10/19/18
10/19
07:40
10/19/18
07:40
Earnings
Honeywell sees Q4 adjusted EPS $1.85-$1.90, consensus $2.09 »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

FTNT

Fortinet

$81.73

0.16 (0.20%)

07:39
10/19/18
10/19
07:39
10/19/18
07:39
Initiation
Fortinet initiated  »

Fortinet initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 10

    Dec

SNY

Sanofi

$44.45

-0.24 (-0.54%)

07:39
10/19/18
10/19
07:39
10/19/18
07:39
Hot Stocks
Sanofi receives positive CHMP opinion for dengue vaccine »

The European Medicines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 29

    Oct

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

TSLA

Tesla

$263.85

-8.09 (-2.97%)

07:39
10/19/18
10/19
07:39
10/19/18
07:39
Recommendations
Tesla analyst commentary  »

Morgan Stanley sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 13

    Dec

CYBR

CyberArk

$70.12

-1.01 (-1.42%)

07:39
10/19/18
10/19
07:39
10/19/18
07:39
Initiation
CyberArk initiated  »

CyberArk initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

WTFC

Wintrust Financial

$79.79

-4.06 (-4.84%)

07:38
10/19/18
10/19
07:38
10/19/18
07:38
Upgrade
Wintrust Financial rating change  »

Wintrust Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BNCL

Beneficial Bancorp

$16.27

-0.18 (-1.09%)

07:37
10/19/18
10/19
07:37
10/19/18
07:37
Earnings
Beneficial Bancorp reports Q3 EPS 17c, consensus 15c »

Reports Q3 CET1 ratio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STNL

Sentinel Energy

$9.81

(0.00%)

, STRK

Strike

$0.00

(0.00%)

07:35
10/19/18
10/19
07:35
10/19/18
07:35
Hot Stocks
Sentinel to buy Strike Capital majority stake, form publicly traded Strike Inc. »

Sentinel Energy Services,…

STNL

Sentinel Energy

$9.81

(0.00%)

STRK

Strike

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGX

Quest Diagnostics

07:35
10/19/18
10/19
07:35
10/19/18
07:35
Initiation
Quest Diagnostics initiated  »

Quest Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

LH

LabCorp

07:35
10/19/18
10/19
07:35
10/19/18
07:35
Initiation
LabCorp initiated  »

LabCorp reinstated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.